With our aging population in the US, the projection for the number of total hip and total knee arthroplasty procedures is expected to increase exponentially over the next 10 – 15 years. These two commonly performed surgeries often involve significant medical cost and carry a potential risk for postoperative complications.
This webinar will explore the clinical benefits of pre-surgical testing in total hip and total knee arthroplasties and discuss the impact that molecular testing can have on patient outcomes and their quality of care. Several areas of patient management will be covered including Joint Commission Disease Specific Certification, MRSA identification and decolonization, and the key stakeholders required to bring a program together.
View VideoIf you would like to be contacted by the sponsor for more information, please provide us with your contact information below.
"*" indicates required fields
